Uterine Lesions and Their Association to Invitro Fertilization(IVF) or Intracytoplasmic Sperm Injection(ICSI) Outcome

Association Between Uterine , Intracavitary , Cervical and Cervical Canal Lesions With in Vitro Fertilization/Intracytoplasmic Sperm Injection(IVF/ICSI) Outcome.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04939376

Enrollment

122

Registered

2021-06-25

Start date

2021-07-01

Completion date

2024-04-01

Last updated

2021-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF

Brief summary

1. To study the effect of uterine wall , intracavitary , cervical as well as cervical canal lesion on the outcome of IVF/ICSI cycle. 2. To establish a score for prediction of IVF/ICSI cycle success .

Detailed description

IVF is one of the most successful treatment of fertility, (1) however, several IVF cycles fail to achieve pregnancy (2).failure defined as three or more failed attempts of ICSI (3). Implantation failure is a complex in nature, may be due to structural or functional causes (3, 4). that previously undiagnosed, misinterpreted initial diagnoses, or subtle newly added intrauterine abnormalities may be a significant cause of IVF failure (5, 6), studies say that intra-uterine pathologies represent 40-50 % of causes of ICSI failure (7, 8), hysteroscopic removal of endometrial polyps, submucous fibroids, uterine septum, or intrauterine adhesions could increase the pregnancy rate (9). so, Evaluation of the uterine cavity may become a routine investigation before assisted reproductive technology(ART) procedures (10). In this study, we evaluate the relationship between the different uterine and cervical pathologies and decreased live birth rate.

Interventions

PROCEDUREIVF

In vitro fertilization

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 38 Years

Healthy volunteers

Yes

Inclusion criteria

* Women between 18 and 38 years old. * An indication for IVF/ICSI.. * Women with BMI between 18.5 : 29.9 . * Women with normal antimullerian hormone(AMH), antral follicle count(AFC) (good responders).

Exclusion criteria

Refusal to join the study. * Women with age less than 18 and more than 38 . * Women with BMI less than 18.5 and more than 30 . * Untreated tubal hydrosalpinges. * Poor responders as assessed by AFC 4 or less ,AMH O.8 ng/dl (nice 2013).

Design outcomes

Primary

Measure	Time frame	Description
Pregnancy rate	Baseline	Pregnancy rate with IVF/ICSI with uterine lesions

Contacts

Primary ContactKhaled Mostafa, Rsedent.dr

khaledmostafa849@yahoo.com0201140465869

Backup ContactMomen Kamel, Prof.dr

Momen_k2000@yahoo.com0201000328901

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026